Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
Document › Details

Evotec AG. (5/16/12). "Press Release: Evotec Becomes the First Contract Research Facility in Europe to Offer Agilent’s RapidFire/MS Screening for Pharmaceutical Drug Discovery". Hamburg.

Region Region Hamburg
  Country Germany
Organisations Organisation Evotec AG (FSE: EVT, TecDAX)
  Today Evotec SE (FSE: EVT, MDA X/TecDAX)
  Group Evotec (Group)
  Organisation 2 Agilent Technologies Deutschland GmbH
Products Product RapidFire™ Mass Spectrometry system
  Product 2 drug screening (HTS)
Index term Index term Evotec–Agilent: mass spectrometer, 201205 supply multiple RapidFire High-throughput MS systems to Hamburg facility
Persons Person Polywka, Mario (Evotec 2019– Supervisory Board Member before 201201–201812 COO RETIRED 12/18)
  Person 2 Salem, Gustavo (Gus) (IDEX 201605 Group President of IDEX Health & Science before Siscapa + Agilent + Assay Designs)
     


Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.

RapidFire, a robust, in-line solid phase extraction technology enables ultrafast, direct analysis of native compounds for a wide variety of biochemical assays including routine ADME and lead discovery applications across a range of therapeutic areas. Evotec is the first Pharmaceutical Contract Research Organisation in Europe to offer these services. The Evotec facility in Hamburg will be equipped with state-of-the-art technology from Agilent including multiple RapidFire High-throughput Mass Spectrometry Systems and 6460 Triple Quadrupole instrumentation.

'Evotec is the ideal partner for Agilent Technologies as we expand this industry-leading platform into the European Contract Research market,' said Gustavo Salem, Agilent Vice President and General Manager, Biological Systems Division. 'Evotec's leadership role as a drug discovery service provider will ensure that this market is exposed to the capabilities of Agilent's RapidFire and gold-standard Mass Spectrometry platforms.'

Mario Polywka, Chief Operating Officer for Evotec commented: 'The addition of Agilent's RapidFire Mass Spectrometry analysis instrumentation and capabilities is a tremendous boost to Evotec's best in class screening platform. Working with Agilent will ensure that these systems are brought into operation quickly and that our partners and collaborators will benefit from further efficiencies in lead discovery.'


Contact Evotec AG: Dr Werner Lanthaler, Chief Executive Officer, Phone: +49.(0)40.56081-242, werner.lanthaler@evotec.com

FORWARD LOOKING STATEMENTS - Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this report. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.

   
Record changed: 2016-03-20

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Evotec (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81




» top